Showing 1 - 9 results of 9 for search 'Bronwyn M Kivell', query time: 0.06s
Refine Results
-
1
-
2
The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies by Martin L. Dalefield, Brittany Scouller, Rabia Bibi, Bronwyn M. Kivell
Published 2022-06-01
Article -
3
-
4
-
5
-
6
The Salvinorin Analogue, Ethoxymethyl Ether Salvinorin B, Promotes Remyelination in Preclinical Models of Multiple Sclerosis by Kelly F. Paton, Kelly F. Paton, Katharina Robichon, Katharina Robichon, Nikki Templeton, Nikki Templeton, Lisa Denny, Lisa Denny, Afnan Al Abadey, Afnan Al Abadey, Dan Luo, Thomas E. Prisinzano, Anne C. La Flamme, Anne C. La Flamme, Anne C. La Flamme, Bronwyn M. Kivell, Bronwyn M. Kivell
Published 2021-12-01
Article -
7
Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in Rodents by Bronwyn M. Kivell, Kelly F. Paton, Nitin Kumar, Aashish S. Morani, Aimee Culverhouse, Amy Shepherd, Susan A. Welsh, Andrew Biggerstaff, Rachel S. Crowley, Thomas E. Prisinzano
Published 2018-10-01
Article -
8
The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depress... by Ross van de Wetering, Amy Ewald, Susan Welsh, Lindsay Kornberger, Samuel E. Williamson, Bryan D. McElroy, Eduardo R. Butelman, Thomas E. Prisinzano, Bronwyn M. Kivell
Published 2023-06-01
Article -
9